Major Events - Xian Dao Intelligent (00470) received a subscription rate of 79.54 times for its public offering in Hong Kong, with a final issue price of HKD 45.8 per share [1] - Shishi Pharmaceutical Group (02005) is expected to win bids for 45 products in the national centralized procurement [1] - Gilead Sciences-B (01672) has selected the oral amylin receptor agonist peptide ASC36 for clinical development [1] - China Railway Construction (01186) recently won major projects totaling CNY 451.42 billion [1] - Shoucheng Holdings (00697) invested in Qimiao Labi through its subsidiary fund, focusing on expanding its product matrix around core intellectual property [1] - Minshi Group (00425) plans to establish a joint venture to produce aluminum body frame components [1] - Fubo Group (03738) has reached a strategic cooperation with Xinglu Technology [1] - Jin Xun Resources (03636) plans to increase capital by a total of USD 44 million for its overseas subsidiaries [1] - Changfei Optical Fiber and Cable (06869) experienced abnormal fluctuations in A-share trading, clarifying that it does not engage in CPO-related businesses [1] Operating Performance - SMIC (00981) reported Q4 revenue of USD 2.489 billion, a quarter-on-quarter increase of 4.5%, with a gross margin of 19.2% [1] - PCCW (00008) reported a loss attributable to shareholders of HKD 253 million for the fiscal year 2025, narrowing by 16% year-on-year [1] - WuXi Biologics (02269) issued a positive profit alert, expecting a year-on-year profit increase of approximately 46.3% to CNY 4.908 billion for the fiscal year 2025 [1] - Dongyue Group (00189) issued a positive profit alert, anticipating over 100% year-on-year growth in profit attributable to owners for 2025 [1] - Elephant Future Group (02309) issued a positive profit alert, expecting a mid-term profit attributable to owners of approximately HKD 178 million, reversing from a loss [1] - Sihuan Pharmaceutical (00460) issued a positive profit alert, expecting revenue of no less than CNY 2.5 billion for 2025, with a growth rate exceeding 30% compared to the previous year [1] - Beijing Automotive (01958) expects a net profit attributable to the parent company of approximately CNY 110 million to CNY 130 million for 2025, a year-on-year decrease of about 86.4% to 88.5% [1] - COFCO Joycome (01610) issued a profit warning, expecting a loss attributable to shareholders of approximately CNY 230 million to CNY 350 million, reversing from profit year-on-year [1] - New Town Development (01030) achieved a contract sales amount of approximately CNY 714 million in January, a year-on-year decrease of 29.79% [1] - Yue Yuen Industrial (00551) reported a net operating income of approximately USD 705 million in January, a year-on-year decrease of 12.5% [1] - Baoshan International (03813) reported a cumulative net operating income of CNY 1.748 billion in January, a year-on-year decline of 32.5% [1]

本公司截至2026年1月31日止1个月的综合累计经营收益净额17.48亿元(2025年：25.89亿元)，与去年同 期相比下跌 32.5%。 宝胜国际(03813)发布公告，2026年1月本公司本月综合经营收益净额(即相当于总销售额减销售折扣及销 售退货)17.48亿元(2025年：25.89亿元)，与去年同月相比下跌 32.5%。 ...

智通财经APP讯，宝胜国际(03813)发布公告，2026年1月本公司本月综合经营收益净额(即相当于总销售 额减销售折扣及销售退货)17.48亿元(2025年：25.89亿元)，与去年同月相比下跌 32.5%。 本公司截至2026年1月31日止1个月的综合累计经营收益净额17.48亿元(2025年：25.89亿元)，与去年同 期相比下跌 32.5%。 ...

Group 1 - The core point of the article is that Baoshan International (03813.HK) reported a significant decline in its net operating revenue for January 2026, amounting to approximately RMB 1.748 billion, which represents a 32.5% decrease compared to the same month last year [1] Group 2 - The company's net operating revenue is calculated as total sales minus sales discounts and sales returns [1] - The reported revenue figure indicates a substantial drop, highlighting potential challenges the company may face in maintaining sales performance [1] - The year-on-year comparison emphasizes the severity of the decline, suggesting a need for strategic reassessment [1]

寶勝國際（ 控 股 ）有 限公司 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 POU SHENG INTERNATIONAL (HOLDINGS) LIMITED （於百慕達註冊成立之有限公司） （股份代號：3813） 二零二六年一月之每月收益公告 本公司為聯交所主板上市公司裕元的子公司。按照國際財務報告準則，裕元被 視為臺灣證交所上市公司寶成工業之子公司。寶成工業根據臺灣證券交易所的 規例規定刊發每月收益公告。 由於裕元於今日公佈其若干綜合財務資料，故本公司根據上市規則第13.09(2)條 及證券及期貨條例第XIVA部刊發本公告，確保及時向投資者提供最新資料。 寶勝國際（控股）有限公司（「本公司」）為香港聯合交易所有限公司（「聯交所」）主 板上市公司裕元工業（集團）有限公司（「裕元」）的子公司。按照國際財務報告準則， 裕元被視為臺灣證券交易所股份有限公司（「臺灣證交所」）上市公司寶成工業股份 有限公司（「寶成工業」）之子公司。根據臺灣證券交易所 ...

证券之星消息，2月6日南向资金减持1.4万股宝胜国际（03813.HK）。近5个交易日中，获南向资金减持 的有5天，累计净减持57.5万股。近20个交易日中，获南向资金减持的有20天，累计净减持181.1万股。 截至目前，南向资金持有宝胜国际（03813.HK）1585.3万股，占公司已发行普通股的0.29%。 宝胜国际（控股）有限公司是一家主要从事经销及零售运动服装和鞋类产品的投资控股公司。该公司通 过两个分部运营业务。销售运动服装和鞋类产品分部从事批发销售运动服装和鞋类产品，并透过其自有 的零售店铺、百货公司专柜及互联网零售。特许专柜销售佣金分部提供商场空间予零售商和分销商以特 许专柜销售。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 董事會會議召開日期 寶勝國際（控股）有限公司（「本公司」）董事會（「董事會」）謹此宣佈，本公司將於二 零二六年三月十一日（星期三）舉行董事會會議，旨在（其中包括）考慮及批准本公 司及其子公司截至二零二五年十二月三十一日止年度經審核綜合業績及其發佈， 以及考慮派發末期股息（如有）。 承董事會命 主席 邱暉堯 香港，二零二六年二月六日 於本公告日期，董事會成員包括： 非執行董事 POU SHENG INTERNATIONAL (HOLDINGS) LIMITED 寶勝國際（ 控 股 ）有 限公司 （於百慕達註冊成立之有限公司） （股份代號：3813） 邱暉堯先生（主席）、蔡佩君女士及李義男先生 執行董事 胡嘉和先生、張舒卿女士（首席執行官）及陳立傑先生（首席財務官） 獨立非執行董事 陳煥鐘先生、馮雷明先生及劉詩亮先生 網址：www.pousheng.com ...

致：香港交易及結算所有限公司 公司名稱: 寶勝國際(控股)有限公司 呈交日期: 2026年2月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 03813 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 30,000,000,000 | HKD | | 0.01 | HKD | | 300,000,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | | | 本月底結存 | | | 30,000,000,000 | HKD | | 0.01 | HKD | | 300,000,000 | 本月底法定/註冊股本總額： HKD 300,000,000 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月 ...

Core Viewpoint - *ST Yuan Shang (603813.SH) expects a significant loss in 2025, with projected total profit ranging from -64 million to -76 million yuan, indicating ongoing financial challenges for the company [1] Financial Projections - The company anticipates a net profit attributable to shareholders of the parent company to be between -58 million and -69 million yuan for the year 2025 [1] - After excluding non-recurring gains and losses, the net profit is expected to range from -62 million to -74 million yuan [1] - Projected operating revenue for 2025 is estimated to be between 321 million and 370 million yuan [1] - When excluding revenue from non-core business activities and income lacking commercial substance, the operating revenue is expected to be between 310 million and 358 million yuan [1]

Core Viewpoint - *ST Yuan Shang (603813.SH) has announced that its stock will be subject to delisting risk warning by the Shanghai Stock Exchange on April 30, 2025, indicating potential termination of listing if certain conditions are met [1] Group 1 - The company’s stock is facing a delisting risk warning due to compliance issues as per the Shanghai Stock Exchange's regulations [1] - Investors are advised to be cautious regarding investment risks associated with the company's stock [1]